Carlota Dobaño

11.3k total citations · 1 hit paper
141 papers, 3.8k citations indexed

About

Carlota Dobaño is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Infectious Diseases. According to data from OpenAlex, Carlota Dobaño has authored 141 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Public Health, Environmental and Occupational Health, 45 papers in Immunology and 29 papers in Infectious Diseases. Recurrent topics in Carlota Dobaño's work include Malaria Research and Control (69 papers), Mosquito-borne diseases and control (35 papers) and SARS-CoV-2 and COVID-19 Research (24 papers). Carlota Dobaño is often cited by papers focused on Malaria Research and Control (69 papers), Mosquito-borne diseases and control (35 papers) and SARS-CoV-2 and COVID-19 Research (24 papers). Carlota Dobaño collaborates with scholars based in Spain, Mozambique and United States. Carlota Dobaño's co-authors include Denise L. Doolan, J. Kevin Baird, Pedro L. Alonso, Gemma Moncunill, Clara Menéndez, Alfredo Mayor, John J. Aponte, Ruth Aguilar, Augusto Nhabomba and Azucena Bardají and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Carlota Dobaño

127 papers receiving 3.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acquired Immunity to Malaria

2009 858 citations Denise L. Doolan, Carlota Dobaño et al. Clinical Microbiology Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlota Dobaño Spain	31	2.5k	1.0k	672	579	554	141	3.8k
John Lusingu Tanzania	36	3.4k 1.4×	1.3k 1.2×	364 0.5×	415 0.7×	539 1.0×	117	4.3k
Peter M. Siba Papua New Guinea	37	2.9k 1.2×	787 0.8×	749 1.1×	929 1.6×	765 1.4×	157	4.8k
Kesinee Chotivanich Thailand	41	4.7k 1.9×	877 0.9×	814 1.2×	709 1.2×	934 1.7×	139	5.9k
Qin Cheng Australia	44	4.8k 2.0×	804 0.8×	625 0.9×	454 0.8×	1.1k 2.0×	134	6.1k
Douglas J. Perkins United States	38	2.3k 0.9×	1.5k 1.5×	539 0.8×	435 0.8×	507 0.9×	128	4.2k
Tsin Wen Yeo Australia	42	4.0k 1.6×	924 0.9×	571 0.8×	746 1.3×	1.0k 1.8×	138	5.6k
Myriam Arévalo‐Herrera Colombia	38	3.5k 1.4×	798 0.8×	712 1.1×	333 0.6×	805 1.5×	126	4.1k
John J. Aponte Spain	34	2.5k 1.0×	407 0.4×	478 0.7×	443 0.8×	586 1.1×	95	4.0k
Jørgen A. L. Kurtzhals Denmark	42	3.1k 1.3×	2.4k 2.3×	609 0.9×	546 0.9×	707 1.3×	162	5.9k
Sodiomon B. Sirima Burkina Faso	37	3.3k 1.3×	721 0.7×	528 0.8×	461 0.8×	751 1.4×	160	4.4k

Countries citing papers authored by Carlota Dobaño

Since Specialization

Citations

This map shows the geographic impact of Carlota Dobaño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlota Dobaño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlota Dobaño more than expected).

Fields of papers citing papers by Carlota Dobaño

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlota Dobaño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlota Dobaño. The network helps show where Carlota Dobaño may publish in the future.

Co-authorship network of co-authors of Carlota Dobaño

This figure shows the co-authorship network connecting the top 25 collaborators of Carlota Dobaño. A scholar is included among the top collaborators of Carlota Dobaño based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlota Dobaño. Carlota Dobaño is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karachaliou, Marianna, Ana Espinosa, Susana Iraola‐Guzmán, et al.. (2025). Risk, determinants, and persistence of long-COVID in a population-based cohort study in Catalonia. BMC Medicine. 23(1). 140–140. 2 indexed citations

Farré, Xavier, Natàlia Blay, Susana Iraola‐Guzmán, et al.. (2025). VEGFA sex-specific signature is associated to long COVID symptom persistence. BMC Medicine. 23(1). 552–552.

Macià, Dídac, Margarita Pons-Salort, Gemma Moncunill, & Carlota Dobaño. (2025). The effect of disease transmission on time-aggregated treatment efficacy estimates: a critical analysis of factors influencing the RTS,S and R21 malaria vaccine phase 3 trials. The Lancet Infectious Diseases. 25(9). e516–e526.

Ramírez‐Morros, Anna, Alfons Jiménez, Marta Vidal, et al.. (2025). Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection. Communications Medicine. 5(1). 243–243.

Alemany, Andrea, Edwards Pradenas, Ruth Aguilar, et al.. (2025). Patient and donor antibody profiles in early COVID-19 convalescent plasma therapy in the COnV-ert trial. Frontiers in Immunology. 16. 1647488–1647488.

Rubio, Rocío, Alexei Yavlinsky, Marina Escalera Zamudio, et al.. (2024). Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later. Journal of Infection. 90(2). 106402–106402. 2 indexed citations

Dobaño, Carlota, Gemma Moncunill, & Quique Bassat. (2024). Getting closer to an effective multi-stage malaria vaccine. The Lancet Infectious Diseases. 24(10). 1063–1064. 1 indexed citations

Rubio, Rocío, Dídac Macià, Diana Barrios, et al.. (2024). High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination. Microbes and Infection. 27(2). 105423–105423. 5 indexed citations

Ribes, Marta, Marta Vidal, Ruth Aguilar, et al.. (2023). Seroprevalence and socioeconomic impact of the first SARS-CoV-2 infection wave in a small town in Navarre, Spain. Scientific Reports. 13(1). 3862–3862. 1 indexed citations

10.

Porta, Miquel, José Pumarega, Magda Gasull, et al.. (2023). Individual blood concentrations of persistent organic pollutants and chemical elements, and COVID-19: A prospective cohort study in Barcelona. Environmental Research. 223. 115419–115419. 9 indexed citations

11.

Aguilar, Ruth, Angeline Cruz, Alfons Jiménez, et al.. (2023). Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations. Travel Medicine and Infectious Disease. 57. 102681–102681. 1 indexed citations

12.

Song, Yong, Ruth Aguilar, Augusto Nhabomba, et al.. (2023). Genetic variants of TLR4, including the novel variant, rs5030719, and related genes are associated with susceptibility to clinical malaria in African children. Malaria Journal. 22(1). 177–177. 2 indexed citations

13.

Jairoce, Chenjerai, Anélsio Cossa, Juliana da Silva, et al.. (2021). Molecular Detection of Soil-Transmitted Helminths and Enteric Protozoa Infection in Children and Its Association with Household Water and Sanitation in Manhiça District, Southern Mozambique. Pathogens. 10(7). 838–838. 4 indexed citations

14.

Ballart, Cristina, Faustino Torrico, Daniel Lozano, et al.. (2021). Clinical and immunological characteristics of tegumentary leishmaniasis cases in Bolivia. PLoS neglected tropical diseases. 15(3). e0009223–e0009223. 8 indexed citations

15.

Tsang, John S., Carlota Dobaño, Pierre Van Damme, et al.. (2020). Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?. Trends in Immunology. 41(6). 457–465. 74 indexed citations

16.

Vidal, Marta, Chenjerai Jairoce, Ruth Aguilar, et al.. (2020). Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique. npj Vaccines. 5(1). 46–46. 16 indexed citations

17.

Beeson, James G., Liriye Kurtovic, Carlota Dobaño, et al.. (2019). Challenges and strategies for developing efficacious and long-lasting malaria vaccines. Science Translational Medicine. 11(474). 137 indexed citations

18.

Campo, Joseph J., Jahit Sacarlal, John J. Aponte, et al.. (2014). Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique. Vaccine. 32(19). 2209–2216. 19 indexed citations

19.

Doolan, Denise L., Carlota Dobaño, & J. Kevin Baird. (2009). Acquired Immunity to Malaria. Clinical Microbiology Reviews. 22(1). 13–36. 858 indexed citations breakdown →

20.

Dobaño, Carlota, Georg Widera, Dietmar Rabussay, & Denise L. Doolan. (2007). Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation. Vaccine. 25(36). 6635–6645. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact